ARCHIVES

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

Statins Associated With Lower Risk Of High-Grade Prostate Cancer

March 25, 2011

Fibrolast Interferon Contract Signed

May 2, 1980

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000

Corrections Made To NCI Phone Directory

May 17, 1991

In Brief: James Institute Receives $9 Million Gift; NCI’s Fraumeni Wins Public Health Award

November 3, 1995

FDA Approves Molecular Test For Breast Cancer Detection

July 27, 2007